Sequential emergence of antibiotic resistance in enterococcal bloodstream isolates over 25 years

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 11, 2002, Pages 3676-3678

  Murdoch, David R ^a   Mirrett, Stanley ^a   Harrell, Lizzie J ^a   Monahan, Janet S ^a   Reller, L Barth ^a  

^a CANTERBURY HEALTH LABORATORIES   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE; GENTAMICIN; STREPTOMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

COLORADO; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; NORTH CAROLINA; POPULATION SURVEILLANCE; TIME FACTORS; UNITED STATES;

EID: 0036838247     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.11.3676-3678.2002     Document Type: Article

References (12)

1. Facklam, R. R., and M. D. Collins. 1989. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J. Clin. Microbiol. 27:731-734.
2. Garbutt, J. M., M. Ventrapragada, B. Littenberg, and L. M. Mundy. 2000. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia. Clin. Infect. Dis. 30:466-472.
3. Gordon, S., J. M. Swenson, B. C. Hill, N. E. Pigott, R. R. Facklam, R. C. Cooksey, C. Thornsberry, Enterococcal Study Group, W. R. Jarvis, and F. C. Tenover. 1992. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. J. Clin. Microbiol. 30:2373-2378.
4. a. Grayson, M. L., G. M. Eliopoulos, C. B. Wennersten, K. L. Ruoff, P. C. De Girolami, M.-J. Ferraro, and R. C. Moellering. 1991. Increasing resistance to β-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob. Agents Chemother. 35:2180-2184.
5. Jones, R. N., H. S. Sader, M. E. Erwin, S. C. Anderson, and the Enterococcus Study Group. 1995. Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Diagn. Microbiol. Infect. Dis. 21:85-93.
6. Low, D. E., N. Keller, A. Barth, and R. N. Jones. 2001. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY antimicrobial surveillance program, 1997-1999. Clin. Infect. Dis. 32(Suppl. 2):S133-S145.
7. Maki, D. G., and W. A. Agger. 1988. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine 67:248-269.
8. Murray, B. E., K. V. Singh, S. M. Markowitz, H. A. Lopardo, J. E. Patterson, M. J. Zervos, E. Rubeglio, G. M. Eliopoulos, L. B. Rice, F. W. Goldstein, S. G. Jenkins, G. M. Caputo, R. Nasnas, L. S. Moore, E. S. Wong, and G. Weinstock. 1991. Evidence for clonal spread of a single strain of β-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states. J. Infect. Dis. 163:780-785.
9. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
10. Noskin, G. A., L. R. Peterson, and J. R. Warren. 1995. Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin. Infect. Dis. 20:296-301.
11. Sahm, D. F., M. K. Marsilio, and G. Piazza. 1999. Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database-USA. Clin. Infect. Dis. 29:259-263.
12. Watanakunakorn, C. 1990. Enterococci from blood cultures during 1980-1989: susceptibility to ampicillin, penicillin and vancomycin. J. Antimicrob. Chemother. 26:602-604.